IL-10 signaling in dendritic cells is required for tolerance induction in a murine model of allergic airway inflammation.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
02 2019
Historique:
received: 27 08 2018
revised: 04 12 2018
accepted: 17 12 2018
pubmed: 20 12 2018
medline: 20 5 2020
entrez: 20 12 2018
Statut: ppublish

Résumé

Allergen specific tolerance induction efficiently ameliorates subsequent allergen induced inflammatory responses. The underlying regulatory mechanisms have been attributed mainly to interleukin (IL)-10 produced by diverse hematopoietic cells, while targets of IL-10 in allergen specific tolerance induction have not yet been well defined. Here, we investigate potential cellular targets of IL-10 in allergen specific tolerance induction using mice with a cell type specific inactivation of the IL-10 receptor gene. Allergic airway inflammation was effectively prevented by tolerance induction in mice with IL-10 receptor (IL-10R) deficiency in T or B cells. Similarly, IL-10R on monocytes/macrophages and/or neutrophils was not required for tolerance induction. In contrast, tolerance induction was impaired in mice that lack IL-10R on dendritic cells: those mice developed an allergic response characterized by a pronounced neutrophilic lung infiltration, which was not ameliorated by tolerogenic treatment. In conclusion, our results show that allergen specific tolerance can be effectively induced without a direct impact of IL-10 on cells of the adaptive immune system, and highlight dendritic cells, but not macrophages nor neutrophils, as the main target of IL-10 during tolerance induction.

Identifiants

pubmed: 30566244
doi: 10.1002/eji.201847883
doi:

Substances chimiques

IL10 protein, mouse 0
Receptors, Interleukin-10 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

302-312

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Anja Dolch (A)

Allergy Research Group, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.

Stefanie Kunz (S)

Allergy Research Group, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.

Britta Dorn (B)

Allergy Research Group, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
Department of Dermatology and Allergology, Experimental Dermatology and Allergy Research Group, University Medical Center Gießen-Marburg, Justus Liebig University Gießen, Gießen, Germany.

Francesca Alessandrini (F)

Center of Allergy and Environment (ZAUM), Technische Universität München and Helmholtz Zentrum München, Munich, Germany.

Werner Müller (W)

Faculty of Life Sciences, University of Manchester, Manchester, UK.

Robert S Jack (RS)

Department of Immunology, Institute of Immunology and Transfusion Medicine, University Hospital of Greifswald, Greifswald, Germany.

Stefan F Martin (SF)

Allergy Research Group, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.

Axel Roers (A)

Institute of Immunology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Dresden, Germany.

Thilo Jakob (T)

Allergy Research Group, Department of Dermatology, Medical Center, University of Freiburg, Freiburg, Germany.
Department of Dermatology and Allergology, Experimental Dermatology and Allergy Research Group, University Medical Center Gießen-Marburg, Justus Liebig University Gießen, Gießen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH